checkAd

    BioLargo (BLGO) – environmental solutions provider (Seite 5)

    eröffnet am 26.08.20 22:10:08 von
    neuester Beitrag 09.10.22 17:31:09 von
    Beiträge: 126
    ID: 1.330.097
    Aufrufe heute: 0
    Gesamt: 3.918
    Aktive User: 0


    Beitrag zu dieser Diskussion schreiben

     Durchsuchen
    • 1
    • 5
    • 13

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 08.12.21 15:15:33
      Beitrag Nr. 86 ()
      👍

      December 8, 2021 2:30 PM
      BioLargo Begins Next Step in Preparing Garratt-Callahan Minimal Liquid Discharge System for Commercial Launch
      https://feeds.issuerdirect.com/news-release.html?newsid=6409…
      Biolargo | 0,225 $
      Avatar
      schrieb am 04.12.21 19:12:20
      Beitrag Nr. 85 ()
      Denke das Pet Odor Procuct könnte was geben. Laut LinkedIn profile "IKIGAI Holdings (IKIGAI), a Nevada Limited Liability Company (LLC) is a consumer brand developer of "Essential" and "Everyday" products that are designed to scale to over $100,000,000 USD in annual sales per product."


      BioLargo Strategic Partnership with Ikigai to Launch New Consumer Product
      Direct to Consumer Test Marketing is Successful

      WESTMINSTER, CA / ACCESSWIRE / November 30, 2021
      https://www.biolargo.com/company-news
      BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it had received a "go decision" from its strategic partner, Ikigai Holdings, LLC, following positive results from the test-marketing phase of a new pet odor control product based on BioLargo's proprietary technology, branded "POOPH". The "go decision" indicates Ikigai's intent to expand television advertising with the goal to launch the product into big-box retailers, and formalizes their exclusive license to the product.

      Jordan Stanley, CPO, IKIGAI
      Chief Product Officer & Co-Founder at IKIGAI

      https://www.linkedin.com/in/jordan-stanley-cpo-ikigai-ba2626…

      IKIGAI Holdings (IKIGAI), a Nevada Limited Liability Company (LLC) is a consumer brand developer of "Essential" and "Everyday" products that are designed to scale to over $100,000,000 USD in annual sales per product. IKIGAI can select and nurture winning consumer product ventures with unparalleled efficiency. My co-founder, Jane Pak and I have over two decades in creating leading consumer brands with global consumer packaged goods (CPG) companies as a proven and trusted partner. IKIGAI has offices on the East and West coast with laboratories focused on sourcing, testing, vetting, and preparing innovative products for mass-market introduction.
      Biolargo | 0,227 $
      1 Antwort
      Avatar
      schrieb am 02.12.21 08:38:36
      Beitrag Nr. 84 ()
      Hoffentlich erhalten wir bald ein Update zu den Tests des zweiten potenziellen Kunden zur PFAS treatment. PFAS ist offensichtlich Big Business und überall in den Nachrichten. Eine Marktchance von mehreren Milliarden US-Dollar. BioLargo bietet die effektivste und kosteneffizienteste PFAS treatment solution.
      Plus Heimvorteil in Orange County und bestehende Geschäftsbeziehungen mit der US-Armee, die viele ihrer Standorte von PFAS befreien muss.

      November 16, 2021
      https://irdirect.net/prviewer/release_only/id/4939360
      First PFAS testing successful - testing of water provided by the company's first prospective PFAS treatment client, a large municipality in southern California, has confirmed that BioLargo's PFAS treatment technology can remove all PFAS compounds of regulatory interest to below State and Federal standards. Additional testing to optimize the AEC underway. Testing with our second prospective client's water is slated to begin next week.

      Biolargo | 0,230 $
      Avatar
      schrieb am 01.12.21 14:43:15
      Beitrag Nr. 83 ()
      BioLargo Signs Manufacturer’s Representative Agreement with ICS Group for its Innovative Water Treatment Technologies
      12/01/2021
      https://www.otcmarkets.com/stock/BLGO/news/BioLargo-Signs-Ma…

      WESTMINSTER, CA / ACCESSWIRE / December 1, 2021 / BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced it has signed a manufacturer's representative agreement with the ICS Group, a premier manufacturer's representative company that has provided innovative wastewater, energy management, and renewable energy technology solutions to municipal and industrial clients, primarily in the Midwestern United States, since 2009. As this is the first manufacturer's representative for BioLargo's innovative water treatment technologies, this represents an important step toward building a commercial network for their sale and distribution.

      ICS Group has been tasked to sell BioLargo's two proprietary water treatment technologies, the Advanced Oxidation System (AOS) energy-efficient wastewater disinfection, micropollutant removal, and water reuse technology, and the Aqueous Electrostatic Concentrator (AEC) technology for affordable, low-waste treatment of PFAS-contaminated water, as well as other water and wastewater treatment equipment that BioLargo offers as an authorized reseller of other manufacturers. The ICS Group will also sell BioLargo's PFAS Testing Program service, which offers fast and affordable testing of clients' PFAS-contaminated water for the purposes of treatment system optimization, and CupriDyne Clean, the company's patented odor and volatile organic compound (VOC) control product.

      Paul Nygaard, President of ICS Group, said, "We specialize in innovative water and wastewater process technologies. We always strive to bring cutting edge technologies to the market that help our clients achieve challenging treatment objectives. BioLargo's unique technology platforms definitely bring that capability to our treatment solutions."

      "ICS Group has a reputation of outstanding customer service, making them the perfect choice to be our first manufacturer's representative for our technologies. They're also known for taking on new and innovative technologies that address unmet needs in the water treatment marketplace," said Tonya Chandler, BioLargo's Director of Strategic Marketing and Business Development. "We intend to add more sales representatives soon and hope they will be as great a fit as the ICS Group to our values."
      Biolargo | 0,227 $
      Avatar
      schrieb am 30.11.21 20:14:43
      Beitrag Nr. 82 ()
      Dieses Projekt hier ist auch sehr interessant. Der Net Present Value dürfte ein vielfaches der derzeitigen Market Cap sein. Könnte man ggf. mit Minenprojekten vergleichen, nur dass man ohne die Technology von BioLargo nichts abbauen kann und man weiter eine Verbindlichkeit in den Büchern für die Abfallentsorgung stehen hat. Diese Projekte sind vermutlich zudem einfacher zu finden als Edelmetallvorkommen…

      July 27, 2021
      https://stockdaymedia.com/biolargo-discusses-pfas-commercial…
      “In our shareholder’s meeting just a few weeks ago, we talked about a very large magnesium project where we’ve taken a waste stream from a mining operation and have shown our client [that we can] convert that to well over a billion in revenue,” said Calvert. “It’s heading into serious negotiations and we’re hoping to bring that to closure in the near future,” he added. “We invented the technology that makes it work.”

      October 08, 2020
      https://irdirect.net/prviewer/release/id/4486872
      Developed a proprietary and patent-pending process to extract valuable mineral resources from a large industrial waste site. As a consequence of this new process, a client is planning a substantial long-term project expected to generate over $1B in revenues for the project. As the client's engineering services provider, and developer of the technology, BioLargo Engineering is in discussions with the client to secure its role as the project manager and/or lead engineer.
      Biolargo | 0,225 $

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,1915EUR +3,79 %
      Aktie kollabiert! Hier der potentielle Nutznießer! mehr zur Aktie »
      Avatar
      schrieb am 30.11.21 16:40:20
      Beitrag Nr. 81 ()
      👍 Das pet odor product ist dann der zweite revenue stream für 2022. Zudem: Garrat-Callahan thinks they can sell at least 30-40 units. The price of one unit is project based between $200 - $500 thousands. First sales expected early 2022.

      BioLargo Strategic Partnership with Ikigai to Launch New Consumer Product
      Direct to Consumer Test Marketing is Successful
      WESTMINSTER, CA / ACCESSWIRE / November 30, 2021
      https://www.biolargo.com/company-news

      BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable cleantech technologies and full-service environmental engineering company, announced that it had received a "go decision" from its strategic partner, Ikigai Holdings, LLC, following positive results from the test-marketing phase of a new pet odor control product based on BioLargo's proprietary technology, branded "POOPH". The "go decision" indicates Ikigai's intent to expand television advertising with the goal to launch the product into big-box retailers, and formalizes their exclusive license to the product.

      Ikigai Holdings, LLC is comprised of veteran consumer product executives with experience launching and growing multiple blockbuster consumer products. Ikigai developed the "POOPH" brand, created television commercials and other advertising content, and then conducted a television direct-response test marketing campaign to assess the probability that the product would be a commercial success.

      Jane Pak, Ikigai CEO, commented, "Early feedback from the test marketing of the POOPH product has been phenomenal. We have placed our initial purchase orders to support an expanded marketing campaign that will begin right after Christmas to gather additional data which will be instrumental in supporting accelerated consumer sales and establishing a strong transition from direct-to-consumer into retail. We are thrilled to see validation that POOPH can disrupt the highly established category of pet odor control products, and with these results, we are already thinking about more products based on BioLargo's technology."

      BioLargo CEO Dennis P. Calvert commented, "Ikigai will purchase the POOPH products from us, and in addition, we receive a royalty on sales. They will finance and manage product roll-out, distribution, and marketing. We are excited about the potential for this partnership to create significant new revenue for both partners. The team at Ikigai is amazing!"
      Biolargo | 0,215 $
      Avatar
      schrieb am 27.11.21 14:26:45
      Beitrag Nr. 80 ()
      Mal sehen was hieraus wird...

      "Another upcoming venture for BioLargo is a consumer odor control product being launched in collaboration with Ikigai Holdings, LLC, whose founders have successfully commercialized five revolutionary consumer products in the past. Together, the two companies intend to create a new mass-market brand based on BioLargo’s technology. BioLargo will serve as the manufacturer and technology licensor. The target is to get to $100 million within four years, Calvert says."

      California’s BioLargo discovers how to purge water of forever chemicals (PFAS) linked to cancer and birth defects
      https://calbizjournal.com/californias-biolargo-discovers-how…

      Letter to Stockholders
      September 30, 2021
      https://feeds.issuerdirect.com/news-release.html?newsid=8816…
      New Consumer Product Partnership

      Over the past six months, we have developed a relationship with a company founded by highly accomplished industry executives from the consumer packaged goods industry who have executed successful launches of at least five blockbuster products, that intends to launch a new consumer product based on our patented BioLargo technology. Our partner, Ikigai Holdings, LLC, has completed preliminary testing, developed the brand, and is in the process of developing television commercials and other marketing materials. It intends to begin test marketing the first product in the coming weeks, and assuming that test marketing phase is successful, will launch the product with the goal to sell to the major retailers in the United States.

      Our agreements provide that we will be the manufacturer of the new product (or products), and they will finance and manage roll-out, distribution, and marketing. We are excited about the potential for this partnership to create significant new revenue channels for BioLargo, but of course, at this point, as confident we are in our new partners, our legal advisors remind us that we cannot predict the future or whether the new product(s) will ultimately find success in the marketplace. With that caveat in place, our partners tell us that the initial television launch will provide highly reliable data indicating the size of the consumer market opportunity. Based on these results, a go-to-market strategy will be determined, and production will be planned.

      Jane Pak, Co-Founder of Ikigai Holdings, offered us this quote: "Creating a mass-market brand begins with finding superior products with unbeatable claims. Our research validated that the current leading odor eliminating products are inferior to the CupriDyne formula and we're thrilled to have the opportunity to disrupt the consumer odor elimination category with such a compelling offer."
      Biolargo | 0,210 $
      Avatar
      schrieb am 18.11.21 22:15:49
      Beitrag Nr. 79 ()
      BioLargo at 'apex of opportunity' as it sees strong engineering division growth in 3Q
      17.11.2021
      BioLargo Inc CEO Dennis Calvert tells Proactive it saw a jump in consolidated revenue during its third quarter. The company generated $712,000 in revenue, a 7% year-over-year increase. Revenue for its engineering division increased by 73% year-over-year and 92% month-over-month. Its net loss during the quarter was reduced to $1.3 million, down from $2.1 million in the year-ago period.

      Biolargo | 0,199 $
      Avatar
      schrieb am 16.11.21 14:49:14
      Beitrag Nr. 78 ()
      👍 möglicher multibagger für 2022...

      BioLargo's Third Quarterly Report for 2021 Details Progress of PFAS Technology Commercialization and Ongoing Partnerships
      November 16, 2021
      https://irdirect.net/prviewer/release_only/id/4939360

      Financial highlights from the 10-Q:


      Consolidated revenue for the three months ended September 30, 2021, was $712,000, a 7% increase compared to the prior year's period. Revenue generated by BioLargo's engineering division increased by 73% compared to last year's period, and 92% as compared with the second quarter of 2021.
      The company's net loss during the quarter was reduced to $1.3 million, down from $2.1 million in the same period of the prior year. The improvement in the company's net loss is due in large part to a significant reduction in interest expenses due to retired debt over the past year.

      Commercial, operational, and R&D highlights:

      First PFAS testing successful - testing of water provided by the company's first prospective PFAS treatment client, a large municipality in southern California, has confirmed that BioLargo's PFAS treatment technology can remove all PFAS compounds of regulatory interest to below State and Federal standards. Additional testing to optimize the AEC underway. Testing with our second prospective client's water is slated to begin next week.
      Garratt-Callahan prototype unit completed - as part of BioLargo's partnership with the water treatment company Garratt-Callahan, BioLargo has just finished building a full-scale prototype unit of their patented "minimal liquid discharge" system for testing on client-provided water. The technology is designed to reduce industrial wastewater discharge and fees associated with discharge. BioLargo engineers will be testing the system's performance soon, and management targets first sales in the early 2022.
      Engineers break revenue record - BioLargo's engineering group's quarter-over-quarter revenue grew by 92% in Q3, having completed over half the work for the $1.2 million worth of engineering projects announced in June of 2021, the remainder of which is expected to complete in the next six months.
      3-year exclusive chemistry supply contract - BioLargo's subsidiary ONM Environmental secured an exclusive three-year CupriDyne Clean supply contract with a large municipality in Southern California.
      TV test marketing shows promising results - a quote from Ikigai Holdings President Jane Pak on the new pet odor product based on BioLargo's technology: "The Ikigai team is pleased to see the product get a positive response early in the market testing period. The next three weeks of media placement will be critical to predicting probability of volume and velocity, but in our first week of placement we are already seeing some very promising results."
      AOS pilot confirms performance - the pilot project in Montreal, Quebec, has confirmed that the AOS is highly effective at removing pharmaceutical micropollutants from municipal wastewater in a real-world setting, faster and using less electricity than major incumbent technologies, making it an attractive product for municipal wastewater treatment customers. A video about this pilot is available here: https://biolargo.blogspot.com/2021/09/biolargo-aos-water-tre…
      Peer-reviewed paper confirms AOS breakthrough - a peer-reviewed scientific paper was published confirming that the AOS generates highly energetic iodine molecules, helping explain why the AOS is a powerful, efficient, and novel water treatment technology. The article, and a summary thereof, can be accessed here: https://biolargo.blogspot.com/2021/09/peer-reviewed-paper-ex…
      Biolargo | 0,173 $
      Avatar
      schrieb am 20.10.21 17:16:38
      Beitrag Nr. 77 ()
      EPA: Chemicals called PFAS will see more research and new regulations
      On Monday, the Environmental Protection Agency announced what it called a "comprehensive national strategy" to handle pollution by a group of industrial chemicals that are collectively called PFAS. These chemicals are relatively inert and persist for decades in the environment; as a result, there are many sites where they pollute the ground or water. And there are some indications that they can cause health issues if they accumulate at sufficient levels.
      [...]

      Source: https://arstechnica.com/tech-policy/2021/10/epa-launches-coo…
      Biolargo | 0,172 $
      • 1
      • 5
      • 13
       DurchsuchenBeitrag schreiben


      BioLargo (BLGO) – environmental solutions provider